First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 12, 2024
VIVO
/
Income Statement
/
Revenue

Meridian Bioscience Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Revenue Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Revenue
$333m
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Revenue
$3.7B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
9%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Revenue
$3.9B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
3%
Align Technology Inc
NASDAQ:ALGN
Revenue
$3.9B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
19%
Lantheus Holdings Inc
NASDAQ:LNTH
Revenue
$1.4B
CAGR 3-Years
59%
CAGR 5-Years
31%
CAGR 10-Years
17%

Meridian Bioscience Inc
Revenue Breakdown

Breakdown by Geography
Meridian Bioscience Inc

Not Available

Breakdown by Segments
Meridian Bioscience Inc

Total Revenue: 333m USD
100%
Life Science: 177.1m USD
53.2%
Diagnostics: 155.9m USD
46.8%
Non Molecular Assays: 137.7m USD
41.4%
Molecular Reagents: 91.8m USD
27.6%
Gastrointestinal Assays: 87.6m USD
26.3%
Immunological Reagents: 85.3m USD
25.6%
Other Diagnostics: 27.5m USD
8.3%
Respiratory Illness Assays: 26.6m USD
8%
Molecular Assays: 18.2m USD
5.5%
Blood Chemistry Assays: 14.2m USD
4.3%
Show More
Show Less

See Also

What is Meridian Bioscience Inc's Revenue?
Revenue
333m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Revenue amounts to 333m USD.

What is Meridian Bioscience Inc's Revenue growth rate?
Revenue CAGR 5Y
11%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Meridian Bioscience Inc have been 18% over the past three years , 11% over the past five years .

ALPHA SPREAD
Join more than 136,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.